Current and future perspectives in the management of juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

Current and future perspectives in the management of juvenile idiopathic arthritis

Published:2018-05 Issue:5 Volume:2 Page:360-370
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Ruperto Nicolino,Martini Alberto

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology and Child Health

Reference100 articles.

1. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

2. Juvenile idiopathic arthritis;Prakken;Lancet,2011

3. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review;Thierry;Joint Bone Spine,2014

4. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997;Petty;J Rheumatol,1998

5. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty;J Rheumatol,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07

2. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study;Annals of the Rheumatic Diseases;2024-06-07

3. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis;Rheumatology;2024-03-29

4. Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis;CPT: Pharmacometrics & Systems Pharmacology;2024-01-31

5. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry;Rheumatology;2024-01-18